Dear Esteemed Authors,
We hope this message finds you well. We regret to inform you that due to unforeseen technical issues, we have encountered a loss of access to the final, closed-copy versions of the Journal of Heart Valve Disease. As a result, we find it necessary to reach out to you, the valued contributors, for your assistance in recovering this crucial content.
We kindly request that each author provide us with the draft copy of their respective articles that have been previously published in the Journal of Heart Valve Disease. We understand the importance of the data and research presented in each article, and we assure you that this request is made with the utmost urgency and diligence.
Upon receiving the draft copies, our team will undertake a thorough process of authentication and verification to ensure the accuracy and integrity of the data. Subsequently, we will proceed with uploading the content to restore closed access to open access for the affected journal articles.
We understand the inconvenience this may cause and sincerely appreciate your cooperation in this matter. We recognize the effort and dedication you have invested in producing high-quality research for the Journal of Heart Valve Disease, and we are committed to resolving this issue as swiftly as possible.
Please submit your draft copies to firstname.lastname@example.org by [Submission Deadline]. If you encounter any challenges or require further assistance, feel free to contact our editorial team at email@example.com
We sincerely apologize for any disruption this may cause and appreciate your understanding and prompt attention to this matter.
Thank you for your continued support and collaboration.
The Journal of Heart Valve Disease
Established in 1992, The Journal of Heart Valve Disease has positioned itself as a key player in the heart valve disease sector. Our core mission is to facilitate global collaboration across various disciplines, transcending geographical boundaries to advance the understanding and treatment of this prevalent medical condition. In a remarkable feat, we earned a coveted spot on Index Medicus within just 18 months of our inception, solidifying our commitment to showcasing cutting-edge research and clinical insights in the field. Since then, we've consistently been at the forefront of disseminating valuable knowledge. Today, our reach extends to 74 countries across five continents, making us a globally recognized source of information. Over the past decade, we've proudly published contributions from clinicians, academics, research scientists, industry experts, and regulatory bodies in 52 countries spanning five continents. We actively seek and welcome a wide range of submissions, including original research publications, thought-provoking editorials, comprehensive reviews, technical papers covering surgery, cardiology, and fundamental science, illustrative case reports, captivating "Image of the Month" features, engaging correspondence, and informative book reviews. Print ISSN: 0966-8519 Online ISSN: 2053-2644
Open Access from Close Access:
Embarking on a Journey of Open Access Discovery
Welcome to the Journal of Heart Valve Disease, where passion for cardiovascular research meets the spirit of open access. Our story is one of evolution, adaptation, and an unyielding commitment to advancing the understanding and treatment of heart valve diseases.
At the heart of our mission is a dedication to excellence in research dissemination. We believe that knowledge should flow freely, transcending geographical and financial boundaries. By embracing open access, we aim to amplify the impact of heart valve disease research on a global scale.
What Drives Us:
The Journal of Heart Valve Disease is fueled by a community of brilliant minds – researchers, healthcare professionals, students, and patients – all connected by a shared goal: to unravel the mysteries of heart valve diseases. We understand that collaborative efforts and open dialogue are essential for progress.
As of 15th of December 2023 , we have officially transitioned to an open-access model. This means that all our articles are now accessible to anyone with an internet connection, free of charge. We invite you to explore our repository of knowledge, from groundbreaking research to insightful reviews, without the hindrance of paywalls.
We remain steadfast in upholding the highest standards of peer review. Our editorial board is comprised of experts dedicated to ensuring the quality, accuracy, and relevance of the research we publish. The move to open access enables us to uphold these standards while facilitating quicker dissemination of critical information.
Whether you're a seasoned researcher, a healthcare practitioner, a student eager to learn, or an individual impacted by heart valve diseases, you play a crucial role in our community. Your engagement, feedback, and contributions are the driving force behind our collective journey.
If you share our passion for advancing cardiovascular research, we invite you to become a part of our community. Explore our open-access articles, submit your groundbreaking research, or simply reach out to connect. Together, we can make a difference in the world of heart valve disease research.
Thank you for being a vital part of the Journal of Heart Valve Disease. We're excited about the future and the discoveries that await on this open-access adventure.
Dear Esteemed Members of the Editorial Board,
We trust this message finds you well. As The Journal of Heart Valve Disease enters a new phase with the resumption of publication from 2023, we express our gratitude for your valuable contributions as part of our esteemed Editorial Board.
Continuation of Positions:
We are delighted to extend an invitation for all existing Editorial Board members to continue holding their positions. Your expertise, insights, and dedication have been instrumental in shaping the success of our journal. We believe that your continued involvement will play a pivotal role in maintaining the high standards of scholarly excellence that The Journal of Heart Valve Disease is known for.
We understand that circumstances and commitments may evolve over time. If any Editorial Board member wishes to step down or adjust their level of involvement, we encourage open communication. Please feel free to contact us at firstname.lastname@example.org with your preferences or if you have any concerns. We value your contributions and respect your decisions.
Why Continue with Us:
Impactful Contributions: Your role as an Editorial Board member has significantly contributed to the success of The Journal of Heart Valve Disease, and we believe that your continued involvement will further enhance the journal's impact in the field.
Collaborative Environment: Joining hands with other experts in the field, you'll be part of a collaborative and dynamic environment dedicated to advancing research in cardiovascular medicine.
Global Recognition:The journal's reputation for quality research, coupled with its indexing in PubMed, provides global recognition for your contributions and enhances the visibility of your association with our esteemed journal.
We appreciate your dedication to advancing scientific knowledge and look forward to your continued collaboration with The Journal of Heart Valve Disease.
For any inquiries or to express your intentions, please email us at email@example.com.
Thank you for being an integral part of our scholarly community.
The Journal of Heart Valve Disease
Dear Esteemed Colleagues and Members of the Scientific Community,
We are pleased to announce the resumption of publication for The Journal of Heart Valve Disease. After a temporary hiatus from 2020 to 2022 due to unforeseen technical challenges, we are now ready to reopen our doors to the scholarly community.
During the past three years, we have received an overwhelming number of emails and inquiries from scholars, researchers, and medical professionals expressing their interest and support for the continuation of The Journal of Heart Valve Disease. Your enthusiasm and commitment to advancing knowledge in this critical field have been truly inspiring.
On behalf of the publisher and the entire editorial team, we want to express our gratitude for your patience and understanding during this challenging period. We understand the importance of providing a platform for the dissemination of groundbreaking research and the exchange of ideas in the realm of heart valve disease.
Starting from 2023, we are officially accepting paper submissions for publication. Researchers and authors are invited to submit their manuscripts for consideration, and we look forward to showcasing the latest advancements, discoveries, and insights in the field of heart valve disease.
The Journal of Heart Valve Disease has always been dedicated to promoting excellence in research and contributing to the collective knowledge that shapes the future of cardiovascular medicine. We are committed to upholding the highest standards of scholarly publishing and ensuring that our journal continues to be a reputable source for cutting-edge research.
We appreciate your continued support and encourage you to submit your valuable contributions to The Journal of Heart Valve Disease. Together, let us advance the understanding of heart valve diseases and contribute to the improvement of patient care and outcomes.
For manuscript submissions and further details, please visit our website or contact our editorial office.
Thank you for your unwavering support, and we look forward to a new chapter of collaboration and innovation in The Journal of Heart Valve Disease.
Xinge Hu, MD & Ph.D, FACC
Cardiologist, Department of Cardiology The Permanente Medical Group Fremont CA 94538, US
The Journal of Heart Valve Disease